| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genomic Structural Variation | 20 | 2024 | 91 | 5.680 |
Why?
|
| Genome, Human | 37 | 2024 | 1852 | 5.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 39 | 2024 | 2349 | 4.820 |
Why?
|
| Sequence Analysis, DNA | 43 | 2024 | 2496 | 4.300 |
Why?
|
| Software | 21 | 2024 | 1342 | 4.070 |
Why?
|
| Genomics | 34 | 2024 | 2846 | 4.060 |
Why?
|
| Haplotypes | 12 | 2024 | 812 | 1.890 |
Why?
|
| Computational Biology | 9 | 2024 | 1280 | 1.810 |
Why?
|
| Polymorphism, Single Nucleotide | 16 | 2024 | 4320 | 1.550 |
Why?
|
| DNA Copy Number Variations | 11 | 2024 | 1546 | 1.390 |
Why?
|
| Genome | 12 | 2024 | 678 | 1.360 |
Why?
|
| Genetic Variation | 15 | 2024 | 2029 | 1.200 |
Why?
|
| Nanopores | 8 | 2022 | 16 | 1.150 |
Why?
|
| DNA Methylation | 6 | 2024 | 2730 | 1.110 |
Why?
|
| Alleles | 6 | 2024 | 2388 | 0.990 |
Why?
|
| Hominidae | 1 | 2024 | 38 | 0.960 |
Why?
|
| Metagenomics | 2 | 2024 | 120 | 0.940 |
Why?
|
| Chromosome Mapping | 7 | 2023 | 1433 | 0.930 |
Why?
|
| Lipoprotein(a) | 1 | 2024 | 129 | 0.890 |
Why?
|
| Polymorphism, Genetic | 2 | 2023 | 1414 | 0.890 |
Why?
|
| Metagenome | 1 | 2024 | 183 | 0.850 |
Why?
|
| Algorithms | 6 | 2022 | 3974 | 0.850 |
Why?
|
| Benchmarking | 8 | 2024 | 290 | 0.840 |
Why?
|
| Mosaicism | 2 | 2024 | 281 | 0.830 |
Why?
|
| Hybridization, Genetic | 3 | 2019 | 17 | 0.800 |
Why?
|
| Cryptosporidium | 1 | 2022 | 46 | 0.800 |
Why?
|
| Industrial Development | 1 | 2021 | 3 | 0.780 |
Why?
|
| Cryptosporidium parvum | 1 | 2022 | 61 | 0.780 |
Why?
|
| Cryptosporidiosis | 1 | 2022 | 87 | 0.780 |
Why?
|
| Germ Cells | 2 | 2024 | 346 | 0.720 |
Why?
|
| Perciformes | 2 | 2017 | 5 | 0.720 |
Why?
|
| DNA Transposable Elements | 3 | 2021 | 227 | 0.710 |
Why?
|
| Microbiota | 1 | 2024 | 547 | 0.600 |
Why?
|
| Transcriptome | 5 | 2024 | 1964 | 0.590 |
Why?
|
| Arabidopsis | 4 | 2019 | 76 | 0.580 |
Why?
|
| INDEL Mutation | 6 | 2024 | 115 | 0.570 |
Why?
|
| Genotype | 7 | 2023 | 4002 | 0.540 |
Why?
|
| Humans | 81 | 2024 | 270605 | 0.530 |
Why?
|
| Sequence Alignment | 3 | 2015 | 844 | 0.520 |
Why?
|
| Genome, Plant | 6 | 2020 | 26 | 0.500 |
Why?
|
| Whole Genome Sequencing | 8 | 2023 | 358 | 0.460 |
Why?
|
| Genetics, Population | 4 | 2024 | 227 | 0.450 |
Why?
|
| DNA Mutational Analysis | 2 | 2019 | 2296 | 0.430 |
Why?
|
| Base Sequence | 9 | 2023 | 4903 | 0.430 |
Why?
|
| Genome-Wide Association Study | 5 | 2023 | 2086 | 0.410 |
Why?
|
| Glucosylceramidase | 3 | 2022 | 25 | 0.410 |
Why?
|
| Cardiovascular Diseases | 1 | 2024 | 2289 | 0.380 |
Why?
|
| Parkinson Disease | 3 | 2023 | 686 | 0.370 |
Why?
|
| Gene Frequency | 3 | 2022 | 1119 | 0.370 |
Why?
|
| Diploidy | 3 | 2020 | 113 | 0.360 |
Why?
|
| DNA, Circular | 2 | 2020 | 33 | 0.360 |
Why?
|
| Exome | 3 | 2023 | 1262 | 0.310 |
Why?
|
| Quantitative Trait Loci | 4 | 2023 | 339 | 0.300 |
Why?
|
| Schizosaccharomyces | 2 | 2019 | 119 | 0.300 |
Why?
|
| Genotyping Techniques | 4 | 2021 | 159 | 0.300 |
Why?
|
| Chromosomes, Human | 4 | 2022 | 278 | 0.300 |
Why?
|
| Circadian Clocks | 2 | 2019 | 66 | 0.290 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2022 | 445 | 0.290 |
Why?
|
| Gene Expression Profiling | 2 | 2021 | 5227 | 0.290 |
Why?
|
| Genome, Fungal | 2 | 2017 | 55 | 0.280 |
Why?
|
| Brain | 4 | 2024 | 4147 | 0.280 |
Why?
|
| Tandem Repeat Sequences | 2 | 2024 | 203 | 0.270 |
Why?
|
| Evolution, Molecular | 4 | 2019 | 854 | 0.270 |
Why?
|
| Genome, Viral | 3 | 2021 | 172 | 0.270 |
Why?
|
| Animals | 20 | 2024 | 61195 | 0.260 |
Why?
|
| Epistasis, Genetic | 3 | 2020 | 108 | 0.250 |
Why?
|
| Sequence Analysis | 2 | 2023 | 72 | 0.240 |
Why?
|
| Pitheciidae | 1 | 2024 | 1 | 0.240 |
Why?
|
| Major Histocompatibility Complex | 2 | 2023 | 88 | 0.240 |
Why?
|
| Genetic Testing | 3 | 2023 | 1672 | 0.240 |
Why?
|
| Gene Duplication | 3 | 2024 | 431 | 0.230 |
Why?
|
| Chromosomes, Human, Y | 1 | 2023 | 52 | 0.220 |
Why?
|
| Adenosine Deaminase | 2 | 2014 | 95 | 0.220 |
Why?
|
| RNA Editing | 2 | 2014 | 91 | 0.210 |
Why?
|
| Gene Expression Regulation, Plant | 2 | 2020 | 73 | 0.210 |
Why?
|
| Cell Line | 4 | 2024 | 5118 | 0.210 |
Why?
|
| Blood Cells | 1 | 2022 | 122 | 0.210 |
Why?
|
| Lewy Body Disease | 1 | 2022 | 20 | 0.210 |
Why?
|
| Chromosomes, Mammalian | 1 | 2022 | 61 | 0.210 |
Why?
|
| Mesocricetus | 1 | 2022 | 116 | 0.200 |
Why?
|
| Human Genome Project | 1 | 2022 | 61 | 0.200 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2022 | 77 | 0.200 |
Why?
|
| DNA | 4 | 2022 | 2732 | 0.190 |
Why?
|
| Gene Rearrangement | 3 | 2023 | 797 | 0.190 |
Why?
|
| Reproductive Isolation | 2 | 2019 | 4 | 0.190 |
Why?
|
| Machine Learning | 1 | 2024 | 362 | 0.190 |
Why?
|
| Bias | 1 | 2021 | 208 | 0.190 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2024 | 5413 | 0.190 |
Why?
|
| Songbirds | 1 | 2020 | 8 | 0.180 |
Why?
|
| Crops, Agricultural | 1 | 2020 | 15 | 0.180 |
Why?
|
| Macaca mulatta | 1 | 2023 | 769 | 0.180 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 540 | 0.180 |
Why?
|
| Mutation | 6 | 2024 | 15649 | 0.180 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2021 | 1231 | 0.180 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2021 | 195 | 0.180 |
Why?
|
| Lymphoma | 2 | 2021 | 1489 | 0.180 |
Why?
|
| Polychondritis, Relapsing | 1 | 2019 | 6 | 0.170 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2022 | 246 | 0.170 |
Why?
|
| Genome, Mitochondrial | 1 | 2019 | 37 | 0.170 |
Why?
|
| Microcephaly | 1 | 2023 | 328 | 0.170 |
Why?
|
| Domestication | 1 | 2019 | 2 | 0.170 |
Why?
|
| Genomic Instability | 1 | 2022 | 524 | 0.170 |
Why?
|
| Annelida | 1 | 2019 | 1 | 0.170 |
Why?
|
| Gaucher Disease | 1 | 2019 | 15 | 0.170 |
Why?
|
| Deafness | 1 | 2019 | 82 | 0.160 |
Why?
|
| Sexual Maturation | 1 | 2019 | 66 | 0.160 |
Why?
|
| Fishes | 1 | 2019 | 52 | 0.160 |
Why?
|
| Workflow | 1 | 2020 | 290 | 0.160 |
Why?
|
| Abnormalities, Multiple | 2 | 2022 | 1010 | 0.160 |
Why?
|
| Arthritis | 1 | 2019 | 144 | 0.160 |
Why?
|
| Introduced Species | 1 | 2017 | 22 | 0.150 |
Why?
|
| Phylogeny | 4 | 2023 | 853 | 0.140 |
Why?
|
| Tidal Waves | 1 | 2016 | 1 | 0.140 |
Why?
|
| Chironomidae | 1 | 2016 | 3 | 0.140 |
Why?
|
| Acclimatization | 1 | 2016 | 43 | 0.140 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2017 | 91 | 0.140 |
Why?
|
| Bass | 1 | 2016 | 2 | 0.140 |
Why?
|
| Heterozygote | 4 | 2022 | 1008 | 0.130 |
Why?
|
| Ananas | 1 | 2015 | 1 | 0.130 |
Why?
|
| Genome, Insect | 1 | 2016 | 102 | 0.130 |
Why?
|
| Photosynthesis | 1 | 2015 | 16 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2019 | 645 | 0.130 |
Why?
|
| Biological Evolution | 1 | 2017 | 269 | 0.130 |
Why?
|
| RNA-Binding Proteins | 3 | 2022 | 1014 | 0.130 |
Why?
|
| Leukemia Virus, Feline | 1 | 2015 | 5 | 0.130 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2019 | 449 | 0.130 |
Why?
|
| Retroviridae Infections | 1 | 2015 | 16 | 0.130 |
Why?
|
| Critical Care | 1 | 2022 | 795 | 0.130 |
Why?
|
| Cat Diseases | 1 | 2015 | 14 | 0.130 |
Why?
|
| Gene Amplification | 1 | 2018 | 745 | 0.130 |
Why?
|
| Phenotype | 6 | 2023 | 6354 | 0.130 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2021 | 1168 | 0.120 |
Why?
|
| Chromatin | 1 | 2020 | 971 | 0.120 |
Why?
|
| Exons | 1 | 2019 | 1346 | 0.120 |
Why?
|
| Intellectual Disability | 1 | 2022 | 1037 | 0.120 |
Why?
|
| Oncogenes | 1 | 2018 | 674 | 0.120 |
Why?
|
| Proteome | 1 | 2019 | 577 | 0.120 |
Why?
|
| Germ-Line Mutation | 1 | 2020 | 1073 | 0.120 |
Why?
|
| Reference Standards | 3 | 2023 | 359 | 0.120 |
Why?
|
| Candida albicans | 1 | 2015 | 182 | 0.120 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2015 | 186 | 0.120 |
Why?
|
| Circadian Rhythm | 1 | 2016 | 336 | 0.120 |
Why?
|
| Papillomavirus Infections | 1 | 2023 | 1009 | 0.120 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2023 | 1132 | 0.120 |
Why?
|
| Precision Medicine | 1 | 2022 | 1213 | 0.120 |
Why?
|
| Computer Simulation | 1 | 2019 | 1528 | 0.120 |
Why?
|
| Tumor Virus Infections | 1 | 2015 | 225 | 0.110 |
Why?
|
| Histone Acetyltransferases | 1 | 2015 | 407 | 0.110 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 365 | 0.110 |
Why?
|
| Ethyl Methanesulfonate | 1 | 2012 | 8 | 0.110 |
Why?
|
| Mutation, Missense | 1 | 2019 | 1185 | 0.110 |
Why?
|
| Candidiasis | 1 | 2015 | 271 | 0.110 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2015 | 296 | 0.110 |
Why?
|
| Genetic Markers | 1 | 2015 | 921 | 0.110 |
Why?
|
| Medical Oncology | 1 | 2021 | 1479 | 0.110 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2024 | 92 | 0.110 |
Why?
|
| Sulfites | 1 | 2012 | 44 | 0.110 |
Why?
|
| Reproducibility of Results | 5 | 2022 | 6172 | 0.100 |
Why?
|
| Nucleotides | 2 | 2022 | 163 | 0.100 |
Why?
|
| Neoplasms | 3 | 2024 | 15799 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 677 | 0.100 |
Why?
|
| Proteomics | 1 | 2019 | 1431 | 0.100 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2021 | 1907 | 0.100 |
Why?
|
| Breast Neoplasms | 3 | 2020 | 16086 | 0.090 |
Why?
|
| Mutagenesis | 1 | 2012 | 481 | 0.090 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2024 | 694 | 0.090 |
Why?
|
| Plant Breeding | 2 | 2020 | 13 | 0.090 |
Why?
|
| Clonal Evolution | 2 | 2023 | 254 | 0.090 |
Why?
|
| MicroRNAs | 2 | 2014 | 2960 | 0.090 |
Why?
|
| Telomere | 2 | 2023 | 517 | 0.090 |
Why?
|
| Molecular Sequence Annotation | 2 | 2020 | 196 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2015 | 1163 | 0.080 |
Why?
|
| Embryo, Mammalian | 1 | 2012 | 754 | 0.080 |
Why?
|
| Databases, Genetic | 2 | 2024 | 751 | 0.080 |
Why?
|
| Chromosome Inversion | 2 | 2020 | 182 | 0.080 |
Why?
|
| MCF-7 Cells | 2 | 2020 | 552 | 0.080 |
Why?
|
| HLA Antigens | 2 | 2021 | 556 | 0.070 |
Why?
|
| Pedigree | 2 | 2023 | 1876 | 0.070 |
Why?
|
| Reproduction | 2 | 2019 | 259 | 0.060 |
Why?
|
| RNA, Viral | 2 | 2021 | 690 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 1507 | 0.060 |
Why?
|
| DNA, Satellite | 1 | 2023 | 35 | 0.060 |
Why?
|
| Segmental Duplications, Genomic | 1 | 2023 | 82 | 0.060 |
Why?
|
| Heterochromatin | 1 | 2023 | 85 | 0.060 |
Why?
|
| Codon, Terminator | 1 | 2023 | 42 | 0.050 |
Why?
|
| Virus Integration | 1 | 2023 | 73 | 0.050 |
Why?
|
| Iran | 1 | 2023 | 73 | 0.050 |
Why?
|
| Qa-SNARE Proteins | 1 | 2022 | 36 | 0.050 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2022 | 48 | 0.050 |
Why?
|
| Multigene Family | 1 | 2023 | 427 | 0.050 |
Why?
|
| Frameshift Mutation | 1 | 2023 | 230 | 0.050 |
Why?
|
| Methylation | 1 | 2023 | 598 | 0.050 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2022 | 132 | 0.050 |
Why?
|
| Endoribonucleases | 1 | 2022 | 110 | 0.050 |
Why?
|
| Base Pair Mismatch | 1 | 2021 | 77 | 0.050 |
Why?
|
| DNA Fingerprinting | 1 | 2021 | 172 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2021 | 14938 | 0.050 |
Why?
|
| Models, Animal | 1 | 2024 | 689 | 0.050 |
Why?
|
| New York City | 1 | 2021 | 76 | 0.050 |
Why?
|
| Linkage Disequilibrium | 1 | 2022 | 425 | 0.050 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2022 | 217 | 0.050 |
Why?
|
| Female | 10 | 2022 | 147401 | 0.050 |
Why?
|
| Open Reading Frames | 1 | 2021 | 245 | 0.050 |
Why?
|
| Leukemia, B-Cell | 1 | 2021 | 114 | 0.050 |
Why?
|
| Ecotype | 1 | 2020 | 9 | 0.050 |
Why?
|
| Inbreeding | 1 | 2020 | 11 | 0.050 |
Why?
|
| Genome, Bacterial | 1 | 2021 | 203 | 0.050 |
Why?
|
| Retroelements | 1 | 2020 | 50 | 0.050 |
Why?
|
| Haploidy | 1 | 2020 | 44 | 0.050 |
Why?
|
| Rare Diseases | 1 | 2023 | 364 | 0.040 |
Why?
|
| Status Epilepticus | 1 | 2022 | 155 | 0.040 |
Why?
|
| Male | 8 | 2023 | 127509 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2021 | 881 | 0.040 |
Why?
|
| Introns | 1 | 2021 | 432 | 0.040 |
Why?
|
| Reference Values | 1 | 2022 | 1123 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2023 | 536 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 2021 | 592 | 0.040 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2021 | 155 | 0.040 |
Why?
|
| Papillomaviridae | 1 | 2023 | 626 | 0.040 |
Why?
|
| Flowers | 1 | 2019 | 9 | 0.040 |
Why?
|
| Transgenes | 1 | 2021 | 573 | 0.040 |
Why?
|
| DNA-Binding Proteins | 2 | 2022 | 4894 | 0.040 |
Why?
|
| Viral Load | 1 | 2021 | 486 | 0.040 |
Why?
|
| Plants, Genetically Modified | 1 | 2019 | 43 | 0.040 |
Why?
|
| Methyltransferases | 1 | 2020 | 149 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2021 | 568 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2021 | 573 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 266 | 0.040 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2020 | 209 | 0.040 |
Why?
|
| Chromosome Breakpoints | 1 | 2019 | 105 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2023 | 8591 | 0.040 |
Why?
|
| Shock, Cardiogenic | 1 | 2022 | 284 | 0.040 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2019 | 71 | 0.040 |
Why?
|
| RNA | 1 | 2024 | 1024 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2021 | 725 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2021 | 343 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 305 | 0.040 |
Why?
|
| Neurogenesis | 1 | 2020 | 245 | 0.040 |
Why?
|
| Fruit | 1 | 2020 | 303 | 0.040 |
Why?
|
| CpG Islands | 1 | 2020 | 643 | 0.040 |
Why?
|
| Chromosome Duplication | 1 | 2019 | 159 | 0.040 |
Why?
|
| Smith-Magenis Syndrome | 1 | 2019 | 127 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2019 | 316 | 0.040 |
Why?
|
| Genome Size | 1 | 2017 | 16 | 0.040 |
Why?
|
| Organoids | 1 | 2020 | 305 | 0.040 |
Why?
|
| Genetic Loci | 1 | 2020 | 462 | 0.040 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2018 | 361 | 0.040 |
Why?
|
| Chromosomes, Fungal | 1 | 2017 | 47 | 0.040 |
Why?
|
| Moon | 1 | 2016 | 13 | 0.040 |
Why?
|
| Basidiomycota | 1 | 2016 | 9 | 0.040 |
Why?
|
| DNA, Plant | 1 | 2016 | 14 | 0.040 |
Why?
|
| CLOCK Proteins | 1 | 2016 | 35 | 0.040 |
Why?
|
| Vitis | 1 | 2016 | 14 | 0.040 |
Why?
|
| Gestational Age | 1 | 2020 | 1110 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2023 | 2874 | 0.030 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2017 | 105 | 0.030 |
Why?
|
| Gene Editing | 1 | 2019 | 231 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 2019 | 619 | 0.030 |
Why?
|
| Chromosome Disorders | 1 | 2019 | 417 | 0.030 |
Why?
|
| DNA, Fungal | 1 | 2016 | 130 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2019 | 356 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2016 | 188 | 0.030 |
Why?
|
| Species Specificity | 1 | 2016 | 775 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2020 | 1471 | 0.030 |
Why?
|
| Cats | 1 | 2015 | 167 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2019 | 1045 | 0.030 |
Why?
|
| DNA Replication | 1 | 2019 | 749 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 2020 | 1916 | 0.030 |
Why?
|
| Virulence | 1 | 2015 | 336 | 0.030 |
Why?
|
| Lymphoma, B-Cell | 1 | 2021 | 923 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 512 | 0.030 |
Why?
|
| Epigenomics | 1 | 2015 | 270 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 901 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2014 | 158 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2021 | 1261 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2020 | 3094 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2016 | 599 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2014 | 5809 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 723 | 0.030 |
Why?
|
| Internet | 1 | 2017 | 744 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 1060 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 1624 | 0.020 |
Why?
|
| Cytosine | 1 | 2012 | 150 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2020 | 5679 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2017 | 1269 | 0.020 |
Why?
|
| Adolescent | 2 | 2022 | 32427 | 0.020 |
Why?
|
| DNA Repair | 1 | 2019 | 1878 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2016 | 826 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2016 | 2258 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 1509 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 5117 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2012 | 318 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 3218 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 694 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2012 | 876 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 3952 | 0.020 |
Why?
|
| Mice | 3 | 2015 | 35470 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 3659 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 3148 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2022 | 5361 | 0.020 |
Why?
|
| Receptor, ErbB-2 | 1 | 2018 | 2637 | 0.020 |
Why?
|
| Binding Sites | 1 | 2012 | 2209 | 0.020 |
Why?
|
| Pregnancy | 1 | 2020 | 7898 | 0.020 |
Why?
|
| Infant | 1 | 2022 | 13886 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 9068 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 5989 | 0.020 |
Why?
|
| Aged | 2 | 2021 | 72892 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2022 | 16878 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 7213 | 0.010 |
Why?
|
| Middle Aged | 2 | 2022 | 89520 | 0.010 |
Why?
|
| Time Factors | 1 | 2016 | 13229 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2012 | 6218 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2019 | 12168 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 80769 | 0.010 |
Why?
|